183 related articles for article (PubMed ID: 38365671)
1. SARS-CoV-2 reinfection with Omicron variant in Shaanxi Province, China: December 2022 to February 2023.
Zhang M; Cao L; Zhang L; Li X; Chen S; Zhang Y
BMC Public Health; 2024 Feb; 24(1):496. PubMed ID: 38365671
[TBL] [Abstract][Full Text] [Related]
2. Incidence and severity of SARS-CoV-2 reinfection, a multicenter cohort study in Shanghai, China.
Yu W; Guo Y; Hu T; Liu Y; Fan Q; Guo L; Zheng B; Kong Y; Zhu H; Yu J; Chen S; Zhang Y; Wang J; Li F; Yang F; Wang Y; Zhu Y; Huang Y; Shen Z; Ruan Y; Mao R; Zhang J
J Med Virol; 2023 Aug; 95(8):e28997. PubMed ID: 37537950
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico.
Peña Rodríguez M; Hernández Bello J; Vega Magaña N; Viera Segura O; García Chagollán M; Ceja Gálvez HR; Mora Mora JC; Rentería Flores FI; García González OP; Muñoz Valle JF
Front Public Health; 2023; 11():1149795. PubMed ID: 37181688
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological and clinical characteristics of COVID-19 reinfection during the epidemic period in Yangzhou city, Jiangsu province.
Wang Y; Liang J; Yang H; Zhu L; Hu J; Xiao L; Huang Y; Dong Y; Wu C; Zhang J; Zhou X
Front Public Health; 2023; 11():1256768. PubMed ID: 37780420
[TBL] [Abstract][Full Text] [Related]
5. The Associated Factors of SARS-CoV-2 Reinfection by Omicron Variant - Guangdong Province, China, December 2022 to January 2023.
Cai C; Li Y; Hu T; Liang R; Wang K; Guo C; Li Y; Zhang M; Kang M
China CDC Wkly; 2023 May; 5(18):391-396. PubMed ID: 37197174
[TBL] [Abstract][Full Text] [Related]
6. Risk of SARS-CoV-2 reinfection by vaccination status, predominant variant and time from prior infection: a cohort study, Reggio Emilia province, Italy, February 2020 to February 2022.
Vicentini M; Venturelli F; Mancuso P; Bisaccia E; Zerbini A; Massari M; Cossarizza A; De Biasi S; Pezzotti P; Bedeschi E; Giorgi Rossi P; ;
Euro Surveill; 2023 Mar; 28(13):. PubMed ID: 36995374
[TBL] [Abstract][Full Text] [Related]
7. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
[TBL] [Abstract][Full Text] [Related]
8. Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study.
Tan CY; Chiew CJ; Pang D; Lee VJ; Ong B; Lye DC; Tan KB
Lancet Infect Dis; 2023 Jul; 23(7):799-805. PubMed ID: 36924786
[TBL] [Abstract][Full Text] [Related]
9. The symptoms and interval of Omicron SARS-CoV-2 reinfection among healthcare workers in a hospital of Southern China: a cross-sectional study.
Ma X; Wang Z; Chen Y; Li Z
BMC Infect Dis; 2024 Mar; 24(1):354. PubMed ID: 38539124
[TBL] [Abstract][Full Text] [Related]
10. SARS CoV-2 reinfection rate is higher in the Omicron variant than in the Alpha and Delta variants.
Özüdoğru O; Bahçe YG; Acer Ö
Ir J Med Sci; 2023 Apr; 192(2):751-756. PubMed ID: 35711013
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological characteristics of 17 imported patients infected with SARS-CoV-2 Omicron variant.
Liu X; Chen M; Zhou Z; Chen D; Mo J; Liu J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):344-351. PubMed ID: 35545327
[TBL] [Abstract][Full Text] [Related]
12. Immune response and severity of Omicron BA.5 reinfection among individuals previously infected with different SARS-CoV-2 variants.
Li L; Xie Z; Li Y; Luo M; Zhang L; Feng C; Tang G; Huang H; Hou R; Xu Y; Jia S; Shi J; Fan Q; Gan Q; Yu N; Hu F; Li Y; Lan Y; Tang X; Li F; Deng X
Front Cell Infect Microbiol; 2023; 13():1277880. PubMed ID: 38188634
[TBL] [Abstract][Full Text] [Related]
13. Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, Canada.
Carazo S; Skowronski DM; Brisson M; Sauvageau C; Brousseau N; Gilca R; Ouakki M; Barkati S; Fafard J; Talbot D; Gilca V; Deceuninck G; Garenc C; Carignan A; De Wals P; De Serres G
JAMA Netw Open; 2022 Oct; 5(10):e2236670. PubMed ID: 36239934
[TBL] [Abstract][Full Text] [Related]
14. Frequency and risk of SARS-CoV-2 reinfections in Norway: a nation-wide study, February 2020 to January 2022.
Bøås H; Storm ML; Tapia G; Kristoffersen AB; Løvlie AL; Størdal K; Lyngstad TM; Bragstad K; Hungnes O; Veneti L
BMC Public Health; 2024 Jan; 24(1):181. PubMed ID: 38225588
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 immune response and reinfection in vaccinated Maya and mestizo in Southeast of Mexico.
Monteón V; León-Pérez F; Ancona-León JG; Gutiérrez-Torres G
Salud Publica Mex; 2023 Dec; 66(1, ene-feb):14-16. PubMed ID: 38065105
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020-31 January 2023.
Cegolon L; Magnano G; Negro C; Larese Filon F;
Viruses; 2023 Jul; 15(7):. PubMed ID: 37515237
[No Abstract] [Full Text] [Related]
17. Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico.
Montes-González JA; Zaragoza-Jiménez CA; Antonio-Villa NE; Fermín-Martínez CA; Ramírez-García D; Vargas-Vázquez A; Gutiérrez-Vargas RI; García-Rodríguez G; López-Gatell H; Valdés-Ferrer SI; Bello-Chavolla OY
Front Public Health; 2023; 11():1146059. PubMed ID: 37081954
[TBL] [Abstract][Full Text] [Related]
18. Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review.
Arabi M; Al-Najjar Y; Sharma O; Kamal I; Javed A; Gohil HS; Paul P; Al-Khalifa AM; Laws S; Zakaria D
BMC Infect Dis; 2023 Jun; 23(1):432. PubMed ID: 37365490
[TBL] [Abstract][Full Text] [Related]
19. Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population.
Wei J; Stoesser N; Matthews PC; Khera T; Gethings O; Diamond I; Studley R; Taylor N; Peto TEA; Walker AS; Pouwels KB; Eyre DW;
Nat Commun; 2024 Feb; 15(1):1008. PubMed ID: 38307854
[TBL] [Abstract][Full Text] [Related]
20. Rapid Increase in Suspected SARS-CoV-2 Reinfections, Clark County, Nevada, USA, December 2021.
Ruff J; Zhang Y; Kappel M; Rathi S; Watkins K; Zhang L; Lockett C
Emerg Infect Dis; 2022 Oct; 28(10):1977-1981. PubMed ID: 35969420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
